Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Fluoxetine: no association with suicidality in obsessive-compulsive disorder.

Beasley CM Jr, Potvin JH, Masica DN, Wheadon DE, Dornseif BE, Genduso LA.

J Affect Disord. 1992 Jan;24(1):1-10.

PMID:
1545040
2.

Evaluation of suicidality during pharmacologic treatment of mood and nonmood disorders.

Tollefson GD, Fawcett J, Winokur G, Beasley CM Jr, Potvin JH, Faries DE, Rampey AH Jr, Sayler ME.

Ann Clin Psychiatry. 1993 Dec;5(4):209-24. Review.

PMID:
8312978
3.

Evaluating suicide-related adverse events in clinical trials of fluoxetine treatment in adults for indications other than major depressive disorder.

Tauscher-Wisniewski S, Disch D, Plewes J, Ball S, Beasley CM.

Psychol Med. 2007 Nov;37(11):1585-93. Review.

PMID:
17640442
4.

Pharmacotherapy of obsessive compulsive disorder--experience with fluoxetine.

Wood A, Tollefson GD, Birkett M.

Int Clin Psychopharmacol. 1993 Winter;8(4):301-6. Review.

PMID:
8277151
5.

[Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].

Etain B, Bonnet-Perrin E.

Encephale. 2001 May-Jun;27(3):280-9. Review. French.

PMID:
11488259
6.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Review. French.

PMID:
18922243
7.
8.

Suicidality in obsessive compulsive disorder (OCD): a systematic review and meta-analysis.

Angelakis I, Gooding P, Tarrier N, Panagioti M.

Clin Psychol Rev. 2015 Jul;39:1-15. doi: 10.1016/j.cpr.2015.03.002. Review.

PMID:
25875222
9.

Akathisia, suicidality, and fluoxetine.

Hamilton MS, Opler LA.

J Clin Psychiatry. 1992 Nov;53(11):401-6. Review.

PMID:
1364815
10.

Fluoxetine and suicidal ideation--a review of the literature.

Crundwell JK.

Int J Neurosci. 1993 Jan;68(1-2):73-84. Review.

PMID:
8063517
11.

Are child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.

Cohen D, Deniau E, Maturana A, Tanguy ML, Bodeau N, Labelle R, Breton JJ, Guile JM.

PLoS One. 2008 Jul 9;3(7):e2632. doi: 10.1371/journal.pone.0002632. Review.

12.

Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placebo.

Tauscher-Wisniewski S, Nilsson M, Caldwell C, Plewes J, Allen AJ.

J Child Adolesc Psychopharmacol. 2007 Oct;17(5):713-8. Review.

PMID:
17979590
13.

Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents.

March JS, Klee BJ, Kremer CM.

J Child Adolesc Psychopharmacol. 2006 Feb-Apr;16(1-2):91-102. Review.

PMID:
16553531
14.

Resilience to suicidality: the buffering hypothesis.

Johnson J, Wood AM, Gooding P, Taylor PJ, Tarrier N.

Clin Psychol Rev. 2011 Jun;31(4):563-91. doi: 10.1016/j.cpr.2010.12.007. Review.

PMID:
21276646

Supplemental Content

Support Center